India
· Delayed Price · Currency is INR RPG Life Sciences Statistics
Total Valuation
RPG Life Sciences has a market cap or net worth of INR 35.78 billion. The enterprise value is 34.52 billion.
| Market Cap | 35.78B |
| Enterprise Value | 34.52B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.33M |
Valuation Ratios
The trailing PE ratio is 50.64.
| PE Ratio | 50.64 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 10.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.14, with an EV/FCF ratio of 77.79.
| EV / Earnings | 48.86 |
| EV / Sales | 5.58 |
| EV / EBITDA | 24.14 |
| EV / EBIT | 27.75 |
| EV / FCF | 77.79 |
Financial Position
The company has a current ratio of 2.04
| Current Ratio | 2.04 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 207.32 |
Financial Efficiency
Return on equity (ROE) is 19.76% and return on invested capital (ROIC) is 21.74%.
| Return on Equity (ROE) | 19.76% |
| Return on Assets (ROA) | 15.31% |
| Return on Capital (ROIC) | 21.74% |
| Revenue Per Employee | 4.87M |
| Profits Per Employee | 556,378 |
| Employee Count | 1,270 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 2.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +59.53% |
| 50-Day Moving Average | 2,343.02 |
| 200-Day Moving Average | 1,932.86 |
| Relative Strength Index (RSI) | 40.82 |
| Average Volume (20 Days) | 1,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RPG Life Sciences had revenue of INR 6.18 billion and earned 706.60 million in profits. Earnings per share was 42.72.
| Revenue | 6.18B |
| Gross Profit | 4.15B |
| Operating Income | 1.24B |
| Pretax Income | 1.04B |
| Net Income | 706.60M |
| EBITDA | 1.43B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | 42.72 |
Balance Sheet
| Cash & Cash Equivalents | 1.26B |
| Total Debt | n/a |
| Net Cash | 1.26B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.79B |
| Book Value Per Share | 229.43 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -620.70 million, giving a free cash flow of 443.80 million.
| Operating Cash Flow | 1.06B |
| Capital Expenditures | -620.70M |
| Free Cash Flow | 443.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.08%, with operating and profit margins of 20.12% and 11.43%.
| Gross Margin | 67.08% |
| Operating Margin | 20.12% |
| Pretax Margin | 16.88% |
| Profit Margin | 11.43% |
| EBITDA Margin | 23.06% |
| EBIT Margin | 20.12% |
| FCF Margin | 7.18% |
Dividends & Yields
RPG Life Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 37.45% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.01% |
| Earnings Yield | 2.00% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |